Dengue Literature Review

Lin2006 - Autoimmune Pathogenesis in Dengue Virus Infection

6 min read

Lin2006 - Autoimmune Pathogenesis in Dengue Virus Infection

Full citation: Lin CF, Wan SW, Cheng HJ, Lei HY, Lin YS. Autoimmune pathogenesis in dengue virus infection. Viral Immunology, 19(2), 127–132 (2006).

Raw file: [[raw/lin2006.pdf]]

Summary

This review from the Lin/Lei group at National Cheng Kung University (NCKU), Taiwan, synthesises their programme of experimental work demonstrating that autoimmune responses — specifically molecular mimicry between dengue virus NS1 and host proteins — contribute to the pathogenesis of dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS). The paper argues that dengue pathogenesis is multifactorial: viral effects (ADE, virus variation, direct cytotoxicity) and immunopathogenesis (inflammatory activation + autoimmunity via molecular mimicry) cooperate to produce the haemorrhagic syndrome (Fig. 2 of paper).

The key experimental evidence summarised is that anti-DV NS1 antibodies, whether from dengue patient sera (DHF/DSS > DF) or from NS1-immunised mice, cross-react with human platelets and endothelial cells, causing functional damage both in vitro and in vivo. Anti-platelet autoantibodies are predominantly IgM, cause complement-mediated lysis, and inhibit ADP-induced aggregation. Anti-endothelial cell autoantibodies induce apoptosis (via NO-mediated upregulation of p53 and Bax, downregulation of Bcl-2 and Bcl-xL, cytochrome c release, and caspase-3 activation) and inflammatory activation (NF-κB pathway → IL-6, IL-8, MCP-1 cytokines; ICAM-1 upregulation; increased PBMC adhesion). The paper also reports preliminary in vivo findings in mice: anti-NS1 increases vascular permeability and causes hepatitis-like pathological effects.

Study Design

  • Type: Review (narrative), synthesising prior experimental work from the same group (Lin et al. 2001–2005)
  • Sample size: N/A (review); underlying studies used patient sera from DHF/DSS and DF patients, HUVEC/endothelial cell lines, platelet preparations, mouse models
  • Setting: National Cheng Kung University Medical College, Tainan, Taiwan; in vitro and murine model experiments
  • Population: DHF/DSS and DF patient sera (Taiwan); comparison with healthy and DF controls

Key Findings

Autoantibody generation in dengue:

  • Anti-platelet and anti-endothelial cell autoantibody levels are higher in DHF/DSS patient sera than in DF patient sera
  • Anti-DV NS1 Abs in patient sera account, at least in part, for this cross-reactivity (demonstrated by absorption experiments)
  • Anti-platelet autoAbs are IgM (not IgG)
  • Dengue patient sera cause complement-mediated platelet lysis and inhibit ADP-induced platelet aggregation
  • Mouse anti-NS1 Abs cross-react with human platelets and produce haemorrhage in mice

Endothelial cell effects of anti-NS1:

  • Anti-NS1 induces endothelial cell apoptosis via nitric oxide (NO) production → p53↑, Bax↑, Bcl-2↓, Bcl-xL↓ → cytochrome c release → caspase-3 activation
  • Anti-NS1 induces endothelial inflammation via tyrosine phosphorylation and NF-κB activation → IL-6↑, IL-8↑, MCP-1↑
  • ICAM-1 upregulation increases adhesion of PBMCs to endothelial cells
  • Anti-NS1 increases endothelial cell monolayer permeability in vitro (unpublished data at time of review)
  • Dye leakage in mice treated with anti-NS1 Abs shows in vivo vascular permeability changes
  • Anti-NS1 causes hepatitis-like pathological effects and endothelial cell apoptosis in murine model (unpublished data)

Vaccine implications:

  • NS1 as vaccine antigen avoids ADE (does not elicit anti-virion Abs) but generates cross-reactive autoAbs
  • The NS1 epitopes responsible for cross-reactivity need to be removed or modified for safe vaccine development
  • Anti-E protein Abs also bind human plasminogen (aa 100–119 of E protein) and inhibit plasmin activity — separate ADE and coagulation concern

Methods Used

  • ELISA / binding assays (patient sera vs platelet and endothelial cell lysates)
  • Absorption experiments (to confirm anti-NS1 contribution to cross-reactivity)
  • Complement-mediated lysis assays
  • Platelet aggregation assays (ADP-induced)
  • Cell culture (HUVEC/endothelial cell lines)
  • Apoptosis assays (NO measurement, Western blot for Bcl-2/Bax/p53/caspase-3)
  • NF-κB reporter assays; cytokine ELISA (IL-6, IL-8, MCP-1)
  • ICAM-1 expression and PBMC adhesion assays
  • Murine models (in vivo vascular permeability, hepatitis-like pathology)

Entities Mentioned

Concepts Addressed

Relevance & Notes

This is a key mechanistic paper connecting NS1 serology to the haemorrhagic syndrome — the most direct link in the wiki between dengue molecular biology and the autoimmune thread. It establishes that:

  1. The target of cross-reactive autoimmunity in DHF/DSS is identifiable — human platelets and endothelial cells
  2. The trigger is anti-NS1 Abs, generated during normal immune response to infection
  3. The mechanism (molecular mimicry) is consistent with the Lin2011 follow-up showing sequence homology between NS1 and host cell surface proteins (PDI, HSP60, vimentin)

The paper reports anti-platelet autoAbs as IgM — contrasting with Garcia2010 - Asymptomatic Dengue FcγRIIa Polymorphism, which relates FcγRIIa (an IgG receptor) to dengue severity. This is not necessarily contradictory: IgM may mediate the acute autoimmune phase (complement lysis, platelet destruction), while IgG-mediated ADE mediates viral re-entry. However, Lin2011 mentions antiplatelet IgG is also present (unpublished at Lin2006 time), and the two may coexist.

The hepatitis-like effect in mouse models (unpublished at time of this review) is consistent with the clinical feature of hepatomegaly in DHF — suggesting anti-NS1 Abs damage liver endothelial cells as well as systemic vasculature. The Garcia2009 post-dengue cohort noted liver enzyme elevations; NS1 molecular mimicry could explain this.

Regarding the gap identified in the 2026-04-12 analysis: this paper directly provides the NS1 molecular mimicry mechanism connecting Infection-Triggered Autoimmunity to dengue biology.

The follow-up review Lin2011 - Molecular Mimicry Virus Host Dengue Pathogenesis (same NCKU group, same programme) extends these findings by naming the specific host-protein targets of anti-NS1 cross-reactivity (PDI, vimentin, HSP60, ATP synthase β-chain), mapping the responsible NS1 domain to the C-terminal aa 311–352, and presenting the WGNGCG flavivirus coagulation motif. Lin2011 should be read alongside this paper for the complete mechanistic picture.

Questions Raised

  1. Is the complement-mediated platelet lysis by IgM anti-NS1 sufficient to account for the full degree of thrombocytopenia in DHF, or does direct DENV infection of megakaryocytes also contribute?
  2. Do anti-NS1 IgM autoAbs persist after acute infection (as Garcia2009 showed for ANA), or do they resolve with the acute IgM response?
  3. Which specific epitopes on NS1 drive cross-reactivity with platelets vs. endothelial cells vs. coagulatory factors — are they overlapping or distinct?
  4. Does the hepatitis-like murine model replicate the clinical hepatomegaly of DHF, and what is the relative contribution of anti-NS1 Abs vs. direct viral cytopathology?

Graph View

Backlinks